StockDrifts LogoStockDrifts

LivesMed 491000

Company
리브스메드LivesMed
Insiders
1
Buys
1
Total Value
₩231K ($161)
Avg Return
+87.24%
Last Filing
2026-07-03

LivesMed (491000) has 1 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩231K ($161) in reported transaction value. The earliest filing StockDrifts holds for LivesMed is dated 2025-12-29; the most recent is 2026-07-03. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +87.24%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2026-07-03BUY주식매수청구권 행사
이동욱
Dongwook Lee
Managing Director51.0K₩34,250+10.5%₩1.7B ($1.2M)
2026-07-03BUY주식매수청구권 행사
장동규
Jang Dong-gyu
Managing Director65.0K₩34,250+10.5%₩2.2B ($1.5M)
2026-07-03BUY주식매수청구권 행사
김욱은
Kim Wook-eun
Managing Director51.0K₩34,250+10.5%₩1.7B ($1.2M)
2026-07-03BUY주식매수청구권 행사
오세윤
Oh Se-yoon
vice president10.6K₩34,250+10.5%₩363M ($252K)
2026-04-15BUY신규선임
김재헌
Jaeheon Kim
moving2.0K₩61,800+1.3%₩124M ($86K)
2026-01-21BUYPROGRAM
이동욱
Dongwook Lee
Managing Director3.0K₩57,200+51.4%₩172M ($119K)
2026-01-21BUYPROGRAM
김욱은
Kim Wook-eun
Managing Director3.0K₩57,200+51.4%₩172M ($119K)
2026-01-21BUYPROGRAM
정순용
Jeong Soon-yong
moving3.0K₩57,200+51.4%₩172M ($119K)
2026-01-21BUYPROGRAM
장동규
Jang Dong-gyu
Managing Director3.0K₩57,200+51.4%₩172M ($119K)
2026-01-21BUYPROGRAM
오세윤
Oh Se-yoon
vice president3.0K₩57,200+51.4%₩172M ($119K)
2026-01-21BUYPROGRAM
배동환
Donghwan Bae
Managing Director135.0K₩57,200+51.4%₩7.7B ($5.4M)
2025-12-29BUYMarket Buy
정순용
Jeong Soon-yong
moving5₩46,250+87.2%₩231K ($161)

Frequently asked questions

Who has been buying LivesMed stock?
1 distinct insiders have filed 1 disclosed insider purchases in LivesMed (491000), most recently on 2026-07-03. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does LivesMed have?
LivesMed has 1 buy-side and 0 sell-side disclosures on record, covering ₩231K ($161) in total reported value, spanning 2025-12-29 to 2026-07-03.
Where does StockDrifts get LivesMed insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for LivesMed. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.